Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Smith

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
BJU International|August 16, 2014
Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, AustraliaJennifer C Rodger, Rajah Supramaniam, Alison J Gibberd, et al.
Asia-Pacific Journal of Clinical Oncology|March 18, 2017
What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?Merehau C Mervin, Anthony Lowe, Robert A Gardiner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 26, 2025
The cost-utility of targeted germline BRCA testing in localized prostate cancer followed by cascade testing first-degree relatives with pathogenic variantsSrinivas Teppala, Paul Scuffham, Kim Edmunds, et al.
European Journal of Mass Spectrometry (Chichester, England)|May 9, 2009
Deciphering drift time measurements from travelling wave ion mobility spectrometry-mass spectrometry studiesDavid P Smith, Tom W Knapman, Iain Campuzano, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2023
Guidelines for genetic testing in prostate cancer: a scoping reviewHaitham Tuffaha, Kim Edmunds, David Fairbairn, et al.
Expert Review of Proteomics|January 13, 2021
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicantsChloe E Spencer, Lucy E Flint, Catherine J Duckett, et al.
Biochemistry|January 9, 2008
Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synucleinDavid P Smith, Deborah J Tew, Andrew F Hill, et al.
BMJ (Clinical Research Ed.)|October 8, 2020
Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective studyCarolyn G Mazariego, Sam Egger, Madeleine T King, et al.
The Medical Journal of Australia|July 25, 2013
Risk factors for erectile dysfunction in a cohort of 108 477 Australian menMarianne F Weber, David P Smith, Dianne L O'Connell, et al.
Familial Cancer|January 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?Kim Edmunds, Shiksha Arora, Sri Teppala, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
BJU International|August 16, 2014
Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, AustraliaJennifer C Rodger, Rajah Supramaniam, Alison J Gibberd, et al.
Asia-Pacific Journal of Clinical Oncology|March 18, 2017
What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?Merehau C Mervin, Anthony Lowe, Robert A Gardiner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 26, 2025
The cost-utility of targeted germline BRCA testing in localized prostate cancer followed by cascade testing first-degree relatives with pathogenic variantsSrinivas Teppala, Paul Scuffham, Kim Edmunds, et al.
European Journal of Mass Spectrometry (Chichester, England)|May 9, 2009
Deciphering drift time measurements from travelling wave ion mobility spectrometry-mass spectrometry studiesDavid P Smith, Tom W Knapman, Iain Campuzano, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2023
Guidelines for genetic testing in prostate cancer: a scoping reviewHaitham Tuffaha, Kim Edmunds, David Fairbairn, et al.
Expert Review of Proteomics|January 13, 2021
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicantsChloe E Spencer, Lucy E Flint, Catherine J Duckett, et al.
Biochemistry|January 9, 2008
Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synucleinDavid P Smith, Deborah J Tew, Andrew F Hill, et al.
BMJ (Clinical Research Ed.)|October 8, 2020
Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective studyCarolyn G Mazariego, Sam Egger, Madeleine T King, et al.
The Medical Journal of Australia|July 25, 2013
Risk factors for erectile dysfunction in a cohort of 108 477 Australian menMarianne F Weber, David P Smith, Dianne L O'Connell, et al.
Familial Cancer|January 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?Kim Edmunds, Shiksha Arora, Sri Teppala, et al.
Pageof 17